PubMed HealthSearch

Biomedical subjects

D K Mayer

Publications and source records attributed to D K Mayer.

16 recordsLinked to original sources

Hazards of chemotherapy. Implementing safe handling practices.

Over the last decade, concerns about the hazards of handling cytotoxic chemotherapeutic agents increased as various studies were published. Analysis of these data suggest possible carcinogenic, teratogenic, and mutagenic risk for health professionals (predominantly nurses and pharmacists) that handle these drugs. However, the research is inconclusive. The nature of the problem, along with methodologic issues, may make it difficult or impossible to provide definitive data on the type and degree of risk for those exposed to chemotherapeutic agents. Guidelines and recommendations have been published by various groups including the Occupational Safety and Health Administration, the American Society of Hospital Pharmacists, the Oncology Nursing Society, and others. In essence, they recommend that only health professionals with specialized training should prepare or administer chemotherapeutic agents. In addition, equipment, unused drugs, and human excreta should be treated as chemically hazardous waste and disposed of according to the individual facility's policies and procedures. These guidelines should provide protection for those involved in preparing chemotherapy for administration, regardless of where this is done. Studies have shown differences in the degree and type of procedures followed and between existing procedures and actual practice. Some of these differences are based on the site of care (e.g., hospital [also influenced by bed size], private practice, or home care). Issues involved in implementing reasonable approaches to lower the relative risk for health-care professionals that handle cytotoxic chemotherapy will be discussed.

Antineoplastic Agents

Prevention, early detection, and management of oncologic emergencies.

The prevention and early detection of oncologic emergencies is critical in caring for the person with cancer. Although many will not develop an oncologic emergency during the course of their illness, the approach outlined in this paper will contribute significantly to the prevention and relief of suffering in those individuals who may develop them.

Cardiovascular Diseases

Obstacles to implementing cancer clinical trials.

There are numerous obstacles to implementing and conducting clinical trials. Patient accrual and the costs of clinical trials are difficult problems for researchers. Additional obstacles to implementing clinical trials are patient-related, physician-related, and nurse-related barriers.

Clinical Trials as Topic

Biotherapy: recent advances and nursing implications.

Nurses have and will continue to play a crucial role in the development and application of new BRM agents and products. Joint ventures between the National Cancer Institute, traditional academic centers, and private industry have produced new partnerships expanding the number and types of biologic research studies being conducted in various patient care settings. Nursing's contributions in these new ventures are significant and ongoing. If not directly involved in studying and administering BRM agents, the nurse will be involved in the education and counseling of persons who may participate in this new cancer treatment modality. Nurses will need to be familiar with BRM because many people will query them about this new field. Dr. Ehrlich concluded his address in 1900 by stating: "We no longer find ourselves lost on a boundless sea, but that we have already caught a distinct glimpse of the land which we hope, nay, which we expect, will yield rich treasures for biology and therapeutics." Are we there yet?

Clinical Trials as Topic

Diagnosis and management of intestinal obstruction in individuals with cancer.

Small bowel obstructions, which account for two-thirds of all intestinal obstruction, are caused by adhesions, hernias and cancer. Large bowel obstructions are usually the result of a malignancy, but may also be caused by diverticulitis or volvulus. Previously treated individuals with a known diagnosis of advanced cancer originating in the pelvis are at highest risk for developing intestinal bowel obstruction. Since 30 percent of Americans will develop cancer in their lifetimes, and colorectal cancer is the most common type, this represents a significant population at risk to be followed by nurse practitioners. The pathophysiology, assessment and management of an individual with a bowel obstruction is reviewed. Morbidity and mortality in this population is high. Wound healing problems, including infection, dehiscence, evisceration and fistula formation, contribute significantly to the morbidity and can cause long-term problems. In today's health care system, it's likely that patients will be discharged from the hospital earlier after bowel surgeries. Therefore, nursing care focusing on wound management is outlined.

Humans

Non-pharmacologic management of pain in the person with cancer.

Management of pain in the person with cancer is a high priority in nursing. Although the actual incidence and severity is not well documented, pain may be experienced at some point by the majority of persons with cancer. Pharmacologic management, by itself, is often not adequate. Nurses must become familiar with non-pharmacologic interventions, to be used alone or in combination with analgesics, for the successful management of cancer pain. This paper discusses various non-pharmacologic options and includes a nursing protocol. More research is warranted to better define those most likely to benefit from these interventions.

Chronic Disease

The future of advanced clinical practice in oncology nursing.

Futures research, a popular field that forecasts the future based on past and present statistics and trends, can help oncology nurses project needs and prepare for the unknown. Projections based on past and present statistics and trends related to health care, nursing, and cancer abound. They provide some guidance but fall short of describing how nurses can best respond to the growing number of patients with cancer, survivors of cancer, their families, and communities. If we can define, measure, and articulate the effect that advanced practice nurses have on patients with cancer, we can determine the most effective way to implement cancer care in the future.

Forecasting